Ellen Agler is CEO of the END Fund, a private philanthropic initiative focused on controlling and eliminating the neglected tropical diseases (NTDs) that affect over 1.5 billion people globally. She has been with the END Fund since its launch in 2012. Agler has worked for over 20 years on global health programs in over 60 countries, serving in roles such as Operation Smile’s senior vice president for international programs, managing programs to provide comprehensive care to children with cleft lips and cleft palates; and director of international operations for International Medical Corps (IMC), focused on international disaster response and delivery of medical care in complex humanitarian emergencies.
Previously
Pharmaceutical advances are expanding, with some exciting new drugs already on the market and others ready to emerge from the pipeline. These therapeutics offer fresh hope fo...